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The power of proteomics in cultured skin fibroblasts from individuals with either
systemic sclerosis or recessive dystrophic epidermolysis bullosa has led to the
common finding of senescence and deficiencies in autophagy. Both of these
disorders exert high demand on fibroblast activity, and without the protective
action of autophagy cellular stress could have many adverse effects that are
further amplified by the senescent phenotype.
Journal of Investigative Dermatology (2014) 134, 2301–2302. doi:10.1038/jid.2014.242
Two recent, related papers in this jour-
nal (Dumit et al., 2014; Kuttner et al.,
2014) have used a proteomic approach
to explore the hypothesis that skin
fibroblasts from an immune-mediated,
fibrotic disorder (systemic sclerosis;
SSc) and from a genetic disease at the
epidermal-dermal junction (recessive
dystrophic epidermolysis bullosa;
RDEB) may share common features
that are associated with the fibrotic/
scarring complications of each condi-
tion. On the surface, SSc and RDEB
represent extremes of cutaneous
integrity, in which excessive, immune-
mediated dermal activation of fibro-
genesis in SSc contrasts with loss of
collagen VII and excessive fragility of
the dermal-epidermal junction that
leads to a continuous cycle of damage
and repair. Dermal events in RDEB
frequently lead to mutilating scarring
as a consequence of persistent
abrasion, blistering, and loss of the
epidermis (Fine et al., 2014).
In the SSc report, Dumit et al. (2014)
conducted a proteomic evaluation of
an aging (up to 33 years) sequence of
dermal fibroblasts using the SILAC
technique, in which intracellular pro-
teins from a reference fibroblast
population were labeled to steady
state with a mixture of two ‘‘heavy’’
(C13, N15)-labeled amino acids. The
reference material was paired with
separate, individual samples, and then
compared for individual protein con-
tent, on a relative basis of abundance,
by LC-MS-MS. Secreted molecules
such as cytokines, matricellular pro-
teins, and matrix proteins were thereby
underrepresented. Among the many
age-dependent differences that were
identified and categorized in these
experiments, the data were used to
focus on the decline in members of
the minichromosome maintenance
helicase complex (MCM), particularly
on MCM6 and MCM7. Both of these
members declined sharply in
abundance in skin fibroblasts from
donors 430 years. Although based on
limited sample sizes, the prevalence of
these proteins was correlated with
declining cell proliferation, increasing
cellular protein content, reduced
autophagic flux, and several addi-
tional markers of cellular senescence,
including the accumulation of
senescence-associated b-galactosidase
(SA-b-gal; Itahana et al., 2007). Having
validated this approach in cells from
normal subjects, a small cohort of SSc
fibroblasts was similarly evaluated and
shown to share the properties of older
donor cells, suggesting that reduced
MCM7/autophagy in SSc could contri-
bute to the senescent phenotype.
This hypothesis was supported by
small interfering RNA knockdown of
MCM7 in normal cells. Interestingly,
accelerated senescence has been re-
ported recently for mesenchymal
stem cells from SSc patients (Cipriani
et al., 2013).
The study of Kuttner et al. (2014)
applied the same SILAC strategy to
identify consistent proteomic differe-
nces between RDEB and age-matched,
normal dermal fibroblasts. As in
the aging/SSc cohorts, the RDEB
cells exhibited reduced autophagic
flux, reduced proliferative activity, and
reduced MCM7 levels, suggesting to
these investigators that the conse-
quences of defective COL7A1 generate
a negative influence on autophagy
and thereby increased levels of cell-
ular stress and cellular senescence.
However, this report places greater
emphasis on the overabundance
of tissue transglutaminase 2 and the
possible effects of altered protein cross-
linking.
The common feature of the two
reports is the proteomic technology used
to compare human skin fibroblast con-
tents in culture and a common deficit in
the clearance of defective organelles
and proteins exhibited by cultured
fibroblasts from two widely different
connective tissue abnormalities that
share a scarring phenotype. Although
molecular depletion (via small interfer-
ing RNA) of MCM7 implicated
the protein as a causative agent for the
increased markers of senescence in nor-
mal cells, there were no complementary
data to show that overexpression of this
marker could rescue all or part of
the senescent phenotype in either SSc
or RDEB fibroblasts. These findings
are certainly thought provoking but not
definitive.
Autophagy is generally described as a
pathway by which cells, through
recycling of organelles and other
structures, maintain sufficient energy
sources to survive physiologic stress
and to evade apoptosis (Green and
Levine, 2014). Various forms of
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cellular stress, including exposure to
reactive oxygen species, result in a
rise in protective autophagy and this
may be accompanied by increased
signs of cellular senescence, including
lower proliferation, increased cell size,
and expression of SA-b-gal. Although
the authors state that reduced auto-
phagy activity indicates elevated stress
(in RDEB), their findings also suggest
that inefficient autophagy may be
the cause, rather than the source, of
increased cellular stress. In addition,
RDEB fibroblasts in culture exhibited
poor adhesion, a factor that could
promote anoikis, which is in itself count-
eracted by autophagy (Yang et al.,
2013).
The two reports illustrate
the power of proteomic
analysis as a hypothesis-
generating tool that can
identify novel pathways
associated with important
pathologies.
Fibrosis is an aspect of both SSc and
RDEB that may contribute to the appar-
ent senescent phenotype through exces-
sive proliferative demands on resident
fibroblasts. Cells from chronic lesions
and scars can acquire a senescent phe-
notype, in which they have a reduced
proliferative capacity that has been
attributed to the elevated expression
of the matricellular protein CCN1
(Jun and Lau, 2010). In turn, the
senescent phenotype is also reported to
shift fibroblasts to a proinflammatory,
senescence-associated secretory pheno-
type (Tchkonia et al., 2013) that can
also alter the growth and repair of
surrounding tissues. The cytokine cloud
associated with senescent cells may
itself have effects on autophagy and
matrix metabolism. Evaluation of the
paracrine effects of SSc and RDEB
fibroblasts on normal counterparts
could test these possibilities.
The process of cellular senescence
occurs both in vivo and in vitro, and
fibroblasts from (much) older human
donors approach that threshold at an
earlier passage number. Some would
argue that any analysis of serially pro-
pagated cells is inherently a selective
process in which the most rapidly pro-
liferating subset (or clone) of cells even-
tually dominates the culture (Maier and
Westendorp, 2009). Indeed, studies of
cellular senescence need to carefully
control for the number of population
doublings. Early- and late-passage cells
may well have different cellular pheno-
types. For these reasons, studies of
senescence-related cell behavior
should make every effort to report the
number of population doublings
undergone by the cultures and to
correlate in vitro findings with intact
tissue.
The mechanical environment is
another modulator of fibroblast behavior
that is gaining in recognition as a mod-
ulator of phenotype. Most fibroblast
analyses are performed on rigid plastic
culture surfaces that may or may not be
coated with specific adhesion mole-
cules. Under these conditions of high
(megapascal) rigidity, fibroblasts often
spontaneously transform into myofibro-
blasts as they seemingly match their
tensional state with that of the environ-
ment. This factor, together with the use
of serum-containing medium, poses
very different, wound-like conditions
on the cultured fibroblasts. In contrast,
these same cells grown on softer sub-
strates show very different cytoskeletal
and membrane architecture, different
gene expression profiles, and prolifera-
tive activities. Although culturing cells
on plastic is universal in biomedical
science, it may be far from physio-
logical.
Despite the limitations of conven-
tional cell culture, the two reports
illustrate the power of proteomic analy-
sis as a hypothesis-generating tool
that can identify novel pathways
associated with important patho-
logies. These studies also remind the
reader that a primary or dominant
defect in extracellular matrix can have
enduring effects, possibly through
selection or epigenetic mechanisms,
to alter many other aspects of cell
behavior.
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